Objective: To explore the ameliorative effect of forsythiaside and its mechanism on learning and memory of composite Alzheimer’s disease (AD) model mice. Methods: Fifty SAMP8 mice of 8 months old were randomly divided into negative control group (gavage of distilled water), positive control group (gavage of donepezil), low-, middle-, and high-dose groups (gavage of forsythiaside 60, 120, and 240 mg/kg, respectively), 10 cases for each group. Another 10 SAMR1 male mice of 8-month old were designed as blank control group (gavage of distilled water). After gavage for 30 consecutive days, Morris water maze test was used to conduct behavioral test 1 h after gavage everyday. 24 h after completing behavior test, the vitality of superoxide dismutase (SOD), acetylcholine esterase (AchE), choline acetyl transferase (ChAT), monoamine oxidase (MAO), and glutathion peroxidase (GSH-PX) as well as the content of malondialdehyde (MDA) and nitric oxide (NO) in brain tissue of mice in each group were tested. Results:In water maze test, forsythiaside could improve the learning and memory ability of composite AD model mice. After being given different doses of forsythiaside for a long term, the activity of SOD, ChAT, and GSH-PX increased inordinately and the content of MDA and NO reduced in varying degrees in a dose-dependent manner. Of all, the high-dose forsythiaside group was the best in therapeutic effect. Conclusion: Forsythiaside has a therapeutic effect on the learning and memory impairment of composite AD model mice probably by regulating the mechanism of the cholinergic system and antioxygenation.
展开▼
